Q203
Sponsors
Qurient Co., Ltd.
Conditions
Healthy Volunteers
Phase 1
A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers
CompletedNCT02530710
Start: 2015-08-31End: 2016-07-31Updated: 2016-12-06
A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers
CompletedNCT02858973
Start: 2016-08-31End: 2018-05-08Updated: 2018-05-14